Cargando…

Relationship Between Soluble Urokinase Plasminogen Activator Receptor (suPAR) and Disease Outcome in Adult-Onset Asthma

BACKGROUND: Soluble urokinase plasminogen activator receptor (suPAR) has emerged as a novel biomarker for various inflammatory conditions and has been proposed to associate with the severity of asthma. However, the relationship between suPAR and clinical asthma features is poorly understood. OBJECTI...

Descripción completa

Detalles Bibliográficos
Autores principales:	Niemelä, Taito, Kankaanranta, Hannu, Vähätalo, Iida, Loponen, Juho, Tuomisto, Leena E, Niemelä, Onni, Hämäläinen, Mari, Moilanen, Eeva, Ilmarinen, Pinja
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9112192/ https://www.ncbi.nlm.nih.gov/pubmed/35592386 http://dx.doi.org/10.2147/JAA.S356083

Ejemplares similares

Planned primary health care asthma contacts during 12-year follow-up after Finnish National Asthma Programme: focus on spirometry
por: Takala, Jaana, et al.
Publicado: (2020)

Long-term adherence to inhaled corticosteroids and asthma control in adult-onset asthma
por: Vähätalo, Iida, et al.
Publicado: (2021)

Participation in scheduled asthma follow-up contacts and adherence to treatment during 12-year follow-up in patients with adult-onset asthma
por: Takala, Jaana, et al.
Publicado: (2022)

Documentation of smoking in scheduled asthma contacts in primary health care: a 12-year follow-up study
por: Takala, Jaana, et al.
Publicado: (2022)

Long-term prognosis of new adult-onset asthma in obese patients
por: Ilmarinen, Pinja, et al.
Publicado: (2021)

Daily physical activity and lung function decline in adult-onset asthma: a 12-year follow-up study
por: Loponen, Juho, et al.
Publicado: (2018)

12-year adherence to inhaled corticosteroids in adult-onset asthma
por: Vähätalo, Iida, et al.
Publicado: (2020)

Effect of asthma control on general health-related quality of life in patients diagnosed with adult-onset asthma
por: Ilmarinen, Pinja, et al.
Publicado: (2019)

Clinical value of bronchodilator response for diagnosing asthma in steroid-naïve adults
por: Tuomisto, Leena E., et al.
Publicado: (2021)

Kinetics of the soluble urokinase plasminogen activator receptor (suPAR) in cirrhosis
por: Garnæs, Emilie, et al.
Publicado: (2019)

Soluble urokinase plasminogen activator receptor (suPAR) in the emergency department: An update
por: Velissaris, Dimitrios, et al.
Publicado: (2022)

Relationship between age and bronchodilator response at diagnosis in adult-onset asthma
por: Tommola, Minna, et al.
Publicado: (2020)

Mitochondria in the Center of Human Eosinophil Apoptosis and Survival
por: Ilmarinen, Pinja, et al.
Publicado: (2014)

Regulation of Spontaneous Eosinophil Apoptosis—A Neglected Area of Importance
por: Ilmarinen, Pinja, et al.
Publicado: (2014)

Phenotypes, Risk Factors, and Mechanisms of Adult-Onset Asthma
por: Ilmarinen, Pinja, et al.
Publicado: (2015)

Seinäjoki Adult Asthma Study (SAAS): a protocol for a 12-year real-life follow-up study of new-onset asthma diagnosed at adult age and treated in primary and specialised care
por: Kankaanranta, Hannu, et al.
Publicado: (2015)

Serum soluble urokinase plasminogen activator receptor (suPAR) in adults with growth hormone deficiency
por: Höybye, Charlotte, et al.
Publicado: (2019)

Soluble Urokinase Plasminogen Activator Receptor (suPAR) Concentrations Are Elevated in Patients with Neuroendocrine Malignancies
por: Özdirik, Burcin, et al.
Publicado: (2020)

Soluble Urokinase Plasminogen Activator Receptor (suPAR) as a Biomarker of Systemic Chronic Inflammation
por: Rasmussen, Line Jee Hartmann, et al.
Publicado: (2021)

Soluble Urokinase Plasminogen Activator Receptor (suPAR) in Autoimmune Rheumatic and Non Rheumatic Diseases
por: Manfredi, Mariangela, et al.
Publicado: (2023)

Increased Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) Levels in Plasma of Suicide Attempters
por: Ventorp, Filip, et al.
Publicado: (2015)

Emerging Comorbidities in Adult Asthma: Risks, Clinical Associations, and Mechanisms
por: Kankaanranta, Hannu, et al.
Publicado: (2016)

Nitric oxide-induced eosinophil apoptosis is dependent on mitochondrial permeability transition (mPT), JNK and oxidative stress: apoptosis is preceded but not mediated by early mPT-dependent JNK activation
por: Ilmarinen-Salo, Pinja, et al.
Publicado: (2012)

The Clinical Value of Soluble Urokinase Plasminogen Activator Receptor (suPAR) Levels in Autoimmune Connective Tissue Disorders
por: Vasarhelyi, Barna, et al.
Publicado: (2016)

Soluble Urokinase Plasminogen Activator Receptor (suPAR) and All-Cause and Cardiovascular Mortality in Diverse Hemodialysis Patients
por: Torino, Claudia, et al.
Publicado: (2018)

Evaluation of soluble urokinase-type plasminogen activator receptor (suPAR) quick test for triage in the emergency department
por: Kumar, Pratyush, et al.
Publicado: (2019)

Comparison of the Mortality Prediction Value of Soluble Urokinase Plasminogen Activator Receptor (suPAR) in COVID-19 and Sepsis
por: Vassiliou, Alice G., et al.
Publicado: (2022)

Soluble urokinase Plasminogen Activator Receptor (suPAR) levels are predictive of COVID-19 severity: an Italian experience
por: Infantino, Maria, et al.
Publicado: (2022)

Serum Levels of Urokinase Plasminogen Activator Receptor (suPAR) Discriminate Moderate Uncontrolled from Severe Asthma
por: Kotsiou, Ourania S., et al.
Publicado: (2022)

Relationship of Circulating Soluble Urokinase Plasminogen Activator Receptor (suPAR) Levels to Disease Control in Asthma and Asthmatic Pregnancy
por: Ivancsó, István, et al.
Publicado: (2013)

Increased Serum Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) Levels in FSGS: A Meta-Analysis
por: Lee, Jiwon M., et al.
Publicado: (2019)

Increased circulating soluble urokinase-type plasminogen activator receptor (suPAR) levels in patients with slow coronary flow
por: Emrah, Acar, et al.
Publicado: (2016)

Soluble Urokinase Plasminogen Activator Receptor (suPAR) Independently Predicts Severity and Length of Hospitalisation in Patients With COVID-19
por: Enocsson, Helena, et al.
Publicado: (2021)

Soluble Urokinase Plasminogen Activator Receptor (suPAR) in the Emergency Department (Ed): A Tool for the Assessment of Elderly Patients
por: Holstein, Ria M., et al.
Publicado: (2022)

Occupational exposures and asthma–COPD overlap in a clinical cohort of adult-onset asthma
por: Tommola, Minna, et al.
Publicado: (2019)

Serum levels of soluble urokinase plasminogen activator receptor (suPAR) predict outcome after resection of colorectal liver metastases
por: Loosen, Sven H., et al.
Publicado: (2018)

The diagnostic value of soluble urokinase-type plasminogen activator receptor (suPAR) for the discrimination of vertebral osteomyelitis and degenerative diseases of the spine
por: Scharrenberg, Jan Simon, et al.
Publicado: (2019)

Soluble urokinase plasminogen activator receptor (suPAR) as an early predictor of severe respiratory failure in patients with COVID-19 pneumonia
por: Rovina, Nikoletta, et al.
Publicado: (2020)

Soluble Urokinase-type Plasminogen Activator Receptor (suPAR) and Impaired Kidney Function in the Population-based Malmö Diet and Cancer Study
por: Schulz, Christina-Alexandra, et al.
Publicado: (2016)

Sex Differences in Circulating Soluble Urokinase‐Type Plasminogen Activator Receptor (suPAR) Levels and Adverse Outcomes in Coronary Artery Disease
por: Mehta, Anurag, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8nqflbvpe54v19ao8nl9heb4sr